The Irish TimesWednesday, 7th October 1998 |
High Court Rejects Grounds Of Challenge To Beet Trials
The High Court yesterday cleared the way for field
trials of
genetically-modified crops in the State when it upheld
the
Environmental Protection Agency's decision to permit
controversial trials of genetically-engineered sugar
beet in Co
Carlow.
In a decision expected to have major implications for
the
biotechnology industry in the State and internationally,
Mr
Justice O'Sullivan rejected all grounds of a challenge
by Ms
Clare Watson, of Genetic Concern, to the field trials
being
conducted by Monsanto plc.
He stressed he was not dealing with the merits or
otherwise of
genetic engineering but rather with legal matters about
the
processing of Monsanto's application by the EPA and Ms
Watson's right to object to it.
The Co Carlow trials were the first such permitted in
the State.
Earlier this year, the EPA also granted consent for four
more
crop trials in Cos Cork, Meath and Wexford. A challenge
to
these is dependent on the outcome of Ms Watson's action.
Ms Watson, of Foster Avenue, Mount Merrion, Dublin, had
argued that the EPA failed to observe the correct
procedures
when granting permission on May 1st, 1997, to Monsanto,
with
an address at High Wycombe, Buckinghamshire, England,
for
the field trials on lands owned by Teagasc at Oak Park,
Co
Carlow.
The court heard Monsanto had developed a sugar beet
plant
which is tolerant of glyphosate, the main ingredient in
Monsanto's weedkiller Roundup. The field trials are
being
conducted to assess the effect of Roundup on that
glyphosate-tolerant sugar beet.
Ms Watson had challenged the EPA's permission for the
field
trials before Mr Justice O'Sullivan over 10 days in
July.
Delivering his 58-page judgment yesterday, the judge
noted that
Ms Watson was not only taking on a heavy onus of proof
in the
action but "the battle ground" had also moved from the
merits
and weight of the "strongly-held opposing opinions" on
genetic
engineering to the legal technicalities governing the
processing
of Monsanto's application for consent for the field
trials and Ms
Watson's right to object, together with the
interpretation of the
legal provisions relating to them.
The judge said there were three main issues. The first
related
to the correct standard which the EPA must apply before
granting consent for field trials.
Ms Watson argued the correct standard was that risks to
the
environment and health must be "effectively zero", while
the
EPA and Monsanto both said the standard was not as high
or
absolute as that, although they did not say precisely
what the
standard was.
A sub-issue was whether the standard set by the 1994
Genetically Modified Regulations, the EPA Act 1992 and
the
1990 European Directive on the Deliberate Release into
the
Environment of Genetically-Modified Organisms, was the
same
throughout.
There was a further sub-issue regarding whether the 1994
regulations and the EPA Act set a higher standard than
the
directive and, if they did, whether they were competent
to do
so.
The judge found that the standard indicated or
contemplated by
the EPA Act was the same as that established by the
directive
and was not the "effectively zero" risk standard
contended for
by Ms Watson.
It was his view that both the Act and directive
contemplated
the possibility that risks would be posed to human
health and the
environment by GMOs in the specific context of
applications
for a deliberate release of these and that both legal
instruments
contemplated not an absolute elimination of all known
risks but
some less absolute form of control.
He said the purpose of the GMO regulations (1994) was to
give
full effect to the directive. He was satisfied the
standard set out
in Article 33.4 of the regulations did not require the
EPA to be
satisfied all risks had been reduced to an effectively
zero level.
He said it was clear that Ms Watson could not establish
the
EPA failed to implement the appropriate standard when
granting consent to Monsanto. He held it to be "a fair
inference" that the EPA accepted the risks to the
environment
as "very low" and no question arose, therefore, of the
agency
applying the incorrect standard or of acting
irrationally.
On the second main issue - whether the 1994 regulations
should
be construed to permit objectors like Ms Watson to make
further comment outside the 21day period specified by
the
regulations in relation to additional material supplied
by
Monsanto in response to an EPA Notice for Particulars -
the
judge also found against Ms Watson.
He accepted the regulations do not make any provision
for
further public submissions and found there was no breach
of
the principles of procedural justice.
The judge also found against Ms Watson on the third main
issue. This related to the EPA by a condition attached
to the
consent granted to Monsanto for the trials, requiring
Monsanto
to submit a field trial management protocol in advance
for
agreement.
Ms Watson argued the EPA had no power to postpone any
part
of its overall consent or to delegate part of its
decision to an
EPA official, Dr Thomas McLoughlin, who was the person
who agreed the protocol with Monsanto and gave the
company
the final go-ahead for the trial.
The judge said he agreed with the EPA that this was a
matter
of "good housekeeping".
Several other points raised by Ms Watson were also
rejected.
The judge found the consent granted to Monsanto was not
in
breach of the requirements of natural or constitutional
justice;
that a newspaper notice acknowledging receipt of
Monsanto's
application was valid; that it was sufficient to publish
this notice
in a local newspaper; that a second newspaper notice was
not
irregular; that it was not necessary to include a map in
the
notification of the trials; that the notifications
complied with the
1994 regulations; and that the EPA gave adequately
prompt
notice of the issuing of its consent to Ms Watson.
After the judgment, Mr John Gordon SC, for Ms Watson,
asked
for an adjournment to allow all sides to consider the
decision.
Mr Justice O'Sullivan adjourned the matter until
Tuesday.
|
|
Monsanto in the UK | Biotech Primer | Knowledge Centre | Discussion Copyright Monsanto Company |
||